Alvotech
NASDAQ:ALVO
| Market Cap (Intraday) | 2.51B |
| Current PE | 25.99 |
| Forward PE | 40.57 |
| 2yr Forward PE | 13.31 |
| 10-Day MA | $8.91 |
| 50-Day MA | $9.67 |
| 200-Day MA | $11.17 |
Alvotech Stock, NASDAQ:ALVO
9, rue de Bitbourg, 28th floor, Luxembourg, Luxembourg 1273
Luxembourg
Phone: +352.422.4500
Number of Employees: 1026
Description
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by R�³bert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.